What Researchers Did
Researchers conducted a controlled clinical trial comparing radiotherapy with hyperbaric oxygen to conventional radiotherapy in air for the management of head and neck cancer.
What They Found
They found that survival and local recurrence-free rates were significantly higher in the hyperbaric oxygen group compared to the conventional radiotherapy group. Effects on normal tissue were similar between both groups, and advanced laryngeal carcinoma showed a distinct improvement with a high survival rate without laryngectomy.
What This Means for Canadian Patients
These early findings suggested that hyperbaric oxygen combined with radiotherapy could offer a therapeutic advantage for Canadian patients with head and neck cancer, potentially improving survival and reducing recurrence. For those with advanced laryngeal carcinoma, this approach might offer a chance for high survival rates while avoiding laryngectomy.
Canadian Relevance
This study has no direct Canadian connection as it was conducted elsewhere.
Study Limitations
As an interim report, the study's findings are preliminary and subject to further data collection and analysis.